Dare Bioscience vs Vistagen Therapeutics
DARE and VTGN side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How DARE and VTGN compare
Dare Bioscience is the larger company, worth 1.3 times as much as Vistagen Therapeutics ($10.1M against $8.0M).
Dare Bioscience keeps more of each dollar of sales as profit, with a net margin of −804% compared with −2475% at Vistagen Therapeutics.
Vistagen Therapeutics scores higher on the StockData Score (9 against 5 for Dare Bioscience), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | DARE | VTGN |
|---|---|---|
| Size and price | ||
| Market cap | $10.1M | $8.0M |
| Share price | $0.657 | $0.180 |
| Change, 1 year | −66.8% | −95.6% |
| Change, 5 years | −96.7% | −99.7% |
| Beta (5Y) | 1.40 | 1.31 |
| Employees | 24 | 41 |
| StockData Score | ||
| Total score | 5 | 9 (better) |
| Valuation score | 0 | 3 (better) |
| Growth score | 0 | 0 |
| Performance score | 1 | 1 |
| Health score | 4 | 5 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 7.4× | 3.4× (better) |
| P/B | – | 0.5× |
| FCF yield | −117% | – |
| Fair value | – | $0.660 |
| Margin of safety | – | 72.7% |
| Growth | ||
| Revenue growth, 5Y average | – | 3.1% |
| Profitability | ||
| Operating margin | −813% (better) | −2542% |
| Net margin | −804% (better) | −2475% |
| FCF margin | −861% | – |
| Return on equity | – | −145% |
| Financial health | ||
| Debt / equity | – | 0.00 |
| Current ratio | 0.99 | 2.64 (better) |
| Altman Z-score | −13.51 (better) | −37.10 |
| Piotroski F-score | 4 (better) | 2 |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 8.5% | 26.5% |
| Held by insiders | 9.4% | 0.52% |
| Short interest, % of float | 7.1% | 5.6% |
Go deeper
- DARE stock overview
- DARE income statement
- DARE valuation and score
- VTGN stock overview
- VTGN income statement
- VTGN valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.